Difference between revisions of "Part:BBa K2918029"
Hafsaflats (Talk | contribs) (→Characterization) |
Weronika77 (Talk | contribs) |
||
(16 intermediate revisions by 3 users not shown) | |||
Line 2: | Line 2: | ||
<partinfo>BBa_K2918029 short</partinfo> | <partinfo>BBa_K2918029 short</partinfo> | ||
− | Linear plasmid for replication by Φ29 replication machinery. | + | Linear plasmid for replication by Φ29 replication machinery, contains GFP and Kanamycin resistance gene. |
Line 12: | Line 12: | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
− | The Φ29 replication mechanism involves replication of a protein-primed based replication linear DNA. Protein primed replication, unlike the conventional DNA or RNA primed mechanism, | + | The Φ29 replication mechanism involves replication of a protein-primed based replication linear DNA. Protein primed replication, unlike the conventional DNA or RNA primed mechanism, does not depend on specific sequences of DNA/RNA which simplifies the design of replication systems. The Φ29 replication can be established by using four simple proteins: Φ29 DNA polymerase <html><a href="https://parts.igem.org/Part:BBa_K2918034">(DNAP/p2)</a></html>, terminal protein <html><a href="https://parts.igem.org/Part:BBa_K2918001">(TP/p3)</a></html>, single stranded binding protein <html><a href="https://parts.igem.org/Part:BBa_K2918002"> (SSB/p5)</a></html> and double stranded binding protein <html><a href="https://parts.igem.org/Part:BBa_K2918003">(DSB/p6)</a></html>. The replication process begins by binding of the Φ29 DNA polymerase and terminal protein complex at the origins of replication (<html><a href="https://parts.igem.org/Part:BBa_K2918033">OriL</a></html> and <html><a href="https://parts.igem.org/Part:BBa_K2918061">OriR</a></html>), which flank the protein-primed linear plasmid <html><a href="#Salas1994">(Salas et al., 1994)</a></html>. The double stranded DNA binding proteins aid in the process of replication and bind more intensely at the origins of replication (OriL and OriR), destabilizing the region and facilitating strand displacement. Single stranded binding proteins bind to the displaced DNA strand preventing strand switching of the DNA polymerase and protecting the linear plasmid from host nucleases <html><a href="#Salas1994">(Salas et al., 1994)</a></html>. The replication mechanism is depicted in Figure 1. If you want to read more about this mechanism, you can take a look at our <html><a target="_blank" href="http://2019.igem.org/Team:TUDelft/Design#orthorep">Design</a></html> page! |
− | The replication process begins by binding of the Φ29 DNA polymerase and terminal protein complex at the origins of replication ( | + | |
<div><ul> | <div><ul> | ||
<center> | <center> | ||
− | <li style="display: inline-block;"> [[File:T--TUDelft--replicationpartstest.jpg|thumb|none|550px|<b>Figure 1:</b> Overview of | + | <li style="display: inline-block;"> [[File:T--TUDelft--replicationpartstest.jpg|thumb|none|550px|<b>Figure 1:</b> Overview of phi29 replication mechanism]] </li> |
</center> | </center> | ||
</ul></div> | </ul></div> | ||
Line 23: | Line 22: | ||
The Φ29 replication system is promising in many ways: | The Φ29 replication system is promising in many ways: | ||
<ul> | <ul> | ||
− | <li>The Φ29 DNA | + | <li>The Φ29 DNA polymerase has the highest processivity of all known single subunit DNA polymerases <html><a href="#Blanco1988">(Blanco et al., 1989)</a></html>, and can be used for whole genome amplification. </li> |
− | <li>The Φ29 machinery along with cell free expression systems can be used to establish the three dogmas of biology in | + | <li>The Φ29 machinery along with cell-free expression systems can be used to establish the three dogmas of biology <I>in vitro</I>, setting the basis for artificial cell development. </li> |
<li>The existing DNA-protein covalent bonds offer many possibilities to engineer the terminal proteins with functional peptide | <li>The existing DNA-protein covalent bonds offer many possibilities to engineer the terminal proteins with functional peptide | ||
sequences. </li> | sequences. </li> | ||
<li>We envision that the unique configuration of the double-stranded, protein-capped linear replicon will be a basis for many | <li>We envision that the unique configuration of the double-stranded, protein-capped linear replicon will be a basis for many | ||
new engineered protein-DNA complexes.</li> | new engineered protein-DNA complexes.</li> | ||
− | <li>Orthogonal replication not only | + | <li>Orthogonal replication enables not only replication independent from the host, but also the ability to engineer the orthogonal |
− | DNA polymerase’s fidelity without introducing mutations in the cell’s genome makes in vivo directed evolution a | + | DNA polymerase’s fidelity without introducing mutations in the cell’s genome which makes <I>in vivo</I> directed evolution a |
possibility. </li></ul> | possibility. </li></ul> | ||
===Characterization=== | ===Characterization=== | ||
To characterize our linear construct we wanted to demonstrate <i>in vitro</i> replication of our linear construct (OriL-GFP-Kan-OriR, link to page) and show that our construct can be propagated by the phi29 replication machinery. | To characterize our linear construct we wanted to demonstrate <i>in vitro</i> replication of our linear construct (OriL-GFP-Kan-OriR, link to page) and show that our construct can be propagated by the phi29 replication machinery. | ||
− | We used an in | + | We used an <I>in vitro</I> transcription-translation system (PUREfrex®2.0) supplemented with dNTPs and purified auxiliary proteins: single stranded binding protein (SSB) and double stranded binding protein (SBD), needed for an efficient DNA replication. We used 1nM as the starting DNA concentration of our OriL-GFP-Kan-OriR with a twofold excess of plasmid DNA encoding for both DNAP and TP. After a 4 hour incubation at 30०C, we purified the DNA from the reaction as described in the complete <html><a target="_blank" href="http://2019.igem.org/Team:TUDelft/Experiments">protocol</a></html>. The size of our construct was determined by DNA gel electrophoresis. As a control, we used samples with and without dNTPs. On our gel, we observed that our linear construct (~2,3 kb) was successfully amplified, as shown in Figure 1. These results show that the phi29 replication machinery can be used for orthogonal DNA replication <I>in vitro</I>. We demonstrated that our origin-flanked linear construct (OriL-GFP-Kan-OriR) can be replicated <I>in vitro</I> by the phi29 minimal replication machinery. |
<div><center><ul> | <div><center><ul> | ||
− | <li style="display: inline-block;"> [[File:T--TUDelft--ivttr.jpg|thumb|none|850px|<b>Figure 1:</b> Purified OriL-GFP-Kan-OriR from a coupled DNA transcription-translation and replication reaction with (+) and without (-) dNTPs, amplified in vitro using the PUREfrex 2.0 system An intense band in the expected size (~2.3 kb) is observed from the +dNTPs reaction, demonstrating the OriL-GFP-Kan-OriR in | + | <li style="display: inline-block;"> [[File:T--TUDelft--ivttr.jpg|thumb|none|850px|<b>Figure 1:</b> Purified OriL-GFP-Kan-OriR from a coupled DNA transcription-translation and replication reaction with (+) and without (-) dNTPs, amplified <I>in vitro</I> using the PUREfrex 2.0 system An intense band in the expected size (~2.3 kb) is observed from the +dNTPs reaction, demonstrating the OriL-GFP-Kan-OriR <I>in vitro</I> replication.]] </li> |
</ul></center></div> | </ul></center></div> | ||
− | Successful replication of our linear construct has been shown on the agarose gel ( | + | Successful replication of our linear construct has been shown on the agarose gel (Figure 1). A very intense band is visible at a size of 2.3 kb, corresponding to the size of OriL-GFP-Kan-OriR construct. This indicates that there has been successful in vitro amplification of our construct. |
===Strain Construction=== | ===Strain Construction=== | ||
− | The construct was assembled by golden gate assembly based modular cloning system. First, the individual transcriptional units were cloned into level 1 destination vectors | + | The construct was assembled by golden gate assembly based modular cloning system. First, the individual transcriptional units were cloned into level 1 destination vectors <html><a target="_blank" href="http://www.addgene.org/48000/">pICH47732</a></html> and <html><a target="_blank" href="http://www.addgene.org/48001/">pICH47742</a></html> by BpiI based golden gate assembly. The multi-transcriptional unit construct was assembled by a BsaI based golden gate. The assembly was a one-pot restriction-ligation reaction where the individual level 1 constructs were added along with the destination vector <html><a target="_blank" href="http://www.addgene.org/48037/">pAGM8031</a></html> and the construct was confirmed by sequencing. The cloning protocol can be found in the MoClo section below. |
===Modular Cloning=== | ===Modular Cloning=== | ||
Line 51: | Line 50: | ||
− | <b>Note: The basic parts sequences of the Sci-Phi 29 collection in the registry contain only the part sequence and therefore contain no overhangs or restriction sites. For synthesizing MoClo compatible parts, refer to table 2. | + | <b>Note: The basic parts sequences of the Sci-Phi 29 collection in the registry contain only the part sequence and therefore contain no overhangs or restriction sites. For synthesizing MoClo compatible parts, refer to table 2.</b> |
Line 199: | Line 198: | ||
<html> | <html> | ||
<ul> | <ul> | ||
− | |||
− | |||
− | |||
− | |||
<li> | <li> | ||
<a id="Blanco1988" href="https://www.ncbi.nlm.nih.gov/pubmed/2498321" target="_blank"> | <a id="Blanco1988" href="https://www.ncbi.nlm.nih.gov/pubmed/2498321" target="_blank"> | ||
Blanco, L., Bernads, A., Lharo, J. M., Martins, G., & Garmendia, C. (1989). Highly Efficient DNA Synthesis by the Phage 429 DNA Polymerase.</a> | Blanco, L., Bernads, A., Lharo, J. M., Martins, G., & Garmendia, C. (1989). Highly Efficient DNA Synthesis by the Phage 429 DNA Polymerase.</a> | ||
</li> | </li> | ||
+ | |||
+ | <li> | ||
+ | <a id="Salas1994" href="https://www.pnas.org/content/91/25/12198" target="_blank"> | ||
+ | Blanco, L., Lázaro, J. M., De Vega, M., Bonnin, A., & Salas, M. (1994). Terminal protein-primed DNA amplification.<i>Proceedings of the National Academy of Sciences of the United States of America</I>.</a> | ||
+ | </li> | ||
+ | |||
</ul> | </ul> | ||
</html> | </html> |
Latest revision as of 06:46, 14 December 2019
OriL-GFP-Kan-OriR
Linear plasmid for replication by Φ29 replication machinery, contains GFP and Kanamycin resistance gene.
Sequence and Features
- 10INCOMPATIBLE WITH RFC[10]Illegal EcoRI site found at 664
Illegal EcoRI site found at 2056 - 12INCOMPATIBLE WITH RFC[12]Illegal EcoRI site found at 664
Illegal EcoRI site found at 2056
Illegal NheI site found at 956 - 21INCOMPATIBLE WITH RFC[21]Illegal EcoRI site found at 664
Illegal EcoRI site found at 2056
Illegal BamHI site found at 873 - 23INCOMPATIBLE WITH RFC[23]Illegal EcoRI site found at 664
Illegal EcoRI site found at 2056 - 25INCOMPATIBLE WITH RFC[25]Illegal EcoRI site found at 664
Illegal EcoRI site found at 2056 - 1000COMPATIBLE WITH RFC[1000]
The part has been confirmed by sequencing and there are no mutations.
Usage and Biology
The Φ29 replication mechanism involves replication of a protein-primed based replication linear DNA. Protein primed replication, unlike the conventional DNA or RNA primed mechanism, does not depend on specific sequences of DNA/RNA which simplifies the design of replication systems. The Φ29 replication can be established by using four simple proteins: Φ29 DNA polymerase (DNAP/p2), terminal protein (TP/p3), single stranded binding protein (SSB/p5) and double stranded binding protein (DSB/p6). The replication process begins by binding of the Φ29 DNA polymerase and terminal protein complex at the origins of replication (OriL and OriR), which flank the protein-primed linear plasmid (Salas et al., 1994). The double stranded DNA binding proteins aid in the process of replication and bind more intensely at the origins of replication (OriL and OriR), destabilizing the region and facilitating strand displacement. Single stranded binding proteins bind to the displaced DNA strand preventing strand switching of the DNA polymerase and protecting the linear plasmid from host nucleases (Salas et al., 1994). The replication mechanism is depicted in Figure 1. If you want to read more about this mechanism, you can take a look at our Design page!
The Φ29 replication system is promising in many ways:
- The Φ29 DNA polymerase has the highest processivity of all known single subunit DNA polymerases (Blanco et al., 1989), and can be used for whole genome amplification.
- The Φ29 machinery along with cell-free expression systems can be used to establish the three dogmas of biology in vitro, setting the basis for artificial cell development.
- The existing DNA-protein covalent bonds offer many possibilities to engineer the terminal proteins with functional peptide sequences.
- We envision that the unique configuration of the double-stranded, protein-capped linear replicon will be a basis for many new engineered protein-DNA complexes.
- Orthogonal replication enables not only replication independent from the host, but also the ability to engineer the orthogonal DNA polymerase’s fidelity without introducing mutations in the cell’s genome which makes in vivo directed evolution a possibility.
Characterization
To characterize our linear construct we wanted to demonstrate in vitro replication of our linear construct (OriL-GFP-Kan-OriR, link to page) and show that our construct can be propagated by the phi29 replication machinery. We used an in vitro transcription-translation system (PUREfrex®2.0) supplemented with dNTPs and purified auxiliary proteins: single stranded binding protein (SSB) and double stranded binding protein (SBD), needed for an efficient DNA replication. We used 1nM as the starting DNA concentration of our OriL-GFP-Kan-OriR with a twofold excess of plasmid DNA encoding for both DNAP and TP. After a 4 hour incubation at 30०C, we purified the DNA from the reaction as described in the complete protocol. The size of our construct was determined by DNA gel electrophoresis. As a control, we used samples with and without dNTPs. On our gel, we observed that our linear construct (~2,3 kb) was successfully amplified, as shown in Figure 1. These results show that the phi29 replication machinery can be used for orthogonal DNA replication in vitro. We demonstrated that our origin-flanked linear construct (OriL-GFP-Kan-OriR) can be replicated in vitro by the phi29 minimal replication machinery.
Successful replication of our linear construct has been shown on the agarose gel (Figure 1). A very intense band is visible at a size of 2.3 kb, corresponding to the size of OriL-GFP-Kan-OriR construct. This indicates that there has been successful in vitro amplification of our construct.
Strain Construction
The construct was assembled by golden gate assembly based modular cloning system. First, the individual transcriptional units were cloned into level 1 destination vectors pICH47732 and pICH47742 by BpiI based golden gate assembly. The multi-transcriptional unit construct was assembled by a BsaI based golden gate. The assembly was a one-pot restriction-ligation reaction where the individual level 1 constructs were added along with the destination vector pAGM8031 and the construct was confirmed by sequencing. The cloning protocol can be found in the MoClo section below.
Modular Cloning
Modular Cloning (MoClo) is a system which allows for efficient one pot assembly of multiple DNA fragments. The MoClo system consists of Type IIS restriction enzymes that cleave DNA 4 to 8 base pairs away from the recognition sites. Cleavage outside of the recognition site allows for customization of the overhangs generated. The MoClo system is hierarchical. First, basic parts (promoters, UTRs, CDS and terminators) are assembled in level 0 plasmids in the kit. In a single reaction, the individual parts can be assembled into vectors containing transcriptional units (level 1). Furthermore, MoClo allows for directional assembly of multiple transcriptional units. Successful assembly of constructs using MoClo can be confirmed by visual readouts (blue/white or red/white screening). For the protocol, you can find it here.
Note: The basic parts sequences of the Sci-Phi 29 collection in the registry contain only the part sequence and therefore contain no overhangs or restriction sites. For synthesizing MoClo compatible parts, refer to table 2.
Level | Basic/Composite | Type | Enzyme |
---|---|---|---|
Level 0 | Basic | Promoters, 5’ UTR, CDS and terminators | BpiI |
Level 1 | Composite | Transcriptional units | BsaI |
Level 2/M/P | Composite | Multiple transcriptional units | BpiI |
For synthesizing basic parts, the part of interest should be flanked by a BpiI site and its specific type overhang. These parts can then be cloned into the respective level 0 MoClo parts. For level 1, where individual transcriptional units are cloned, the overhangs come from the backbone you choose. The restriction sites for level 1 are BsaI. However, any type IIS restriction enzyme could be used.
Table 2: Type specific overhangs and backbones for MoClo. Green indicates the restriction enzyme recognition site. Blue indicates the specific overhangs for the basic parts
Basic Part | Sequence 5' End | Sequence 3' End | Level 0 backbone |
---|---|---|---|
Promoter | NNNN GAAGAC NN GGAG | TACT NN GTCTTC NNNN | pICH41233 |
5’ UTR | NNNN GAAGAC NN TACT | AATG NN GTCTTC NNNN | pICH41246 |
CDS | NNNN GAAGAC NN AATG | GCTT NN GTCTTC NNNN | pICH41308 |
Terminator | NNNN GAAGAC NN GCTT | CGCT NN GTCTTC NNNN | pICH41276 |
References
- Blanco, L., Bernads, A., Lharo, J. M., Martins, G., & Garmendia, C. (1989). Highly Efficient DNA Synthesis by the Phage 429 DNA Polymerase.
- Blanco, L., Lázaro, J. M., De Vega, M., Bonnin, A., & Salas, M. (1994). Terminal protein-primed DNA amplification.Proceedings of the National Academy of Sciences of the United States of America.